HU182920B - Process for preparing stable pharmaceutical compositions containing cyclosporin - Google Patents

Process for preparing stable pharmaceutical compositions containing cyclosporin Download PDF

Info

Publication number
HU182920B
HU182920B HU79SA3166A HUSA003166A HU182920B HU 182920 B HU182920 B HU 182920B HU 79SA3166 A HU79SA3166 A HU 79SA3166A HU SA003166 A HUSA003166 A HU SA003166A HU 182920 B HU182920 B HU 182920B
Authority
HU
Hungary
Prior art keywords
cyclosporin
weight
formulation
pharmaceutical compositions
oil
Prior art date
Application number
HU79SA3166A
Other languages
English (en)
Hungarian (hu)
Inventor
Thomas Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HU182920B publication Critical patent/HU182920B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU79SA3166A 1978-03-07 1979-03-05 Process for preparing stable pharmaceutical compositions containing cyclosporin HU182920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH246178A CH636013A5 (en) 1978-03-07 1978-03-07 More readily absorbable pharmaceutical composition

Publications (1)

Publication Number Publication Date
HU182920B true HU182920B (en) 1984-03-28

Family

ID=4234340

Family Applications (1)

Application Number Title Priority Date Filing Date
HU79SA3166A HU182920B (en) 1978-03-07 1979-03-05 Process for preparing stable pharmaceutical compositions containing cyclosporin

Country Status (4)

Country Link
BE (1) BE874628A (fr)
CH (1) CH636013A5 (fr)
HU (1) HU182920B (fr)
ZA (1) ZA791056B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
DK0642332T3 (da) 1992-05-13 1997-06-16 Sandoz Ltd Ophthalmiske præparater indeholdende cyclosporin
SK277092A3 (en) * 1992-09-07 1996-08-07 Galena As Medicaments with n-methylated cyclic undecapeptides
EP1142568A1 (fr) 1992-09-25 2001-10-10 Novartis AG Compositions pharmaceutiques à base de cyclosporines
WO1996014079A1 (fr) 1994-11-03 1996-05-17 Arzneimittelwerk Dresden Gmbh Nouvelles formes de preparations de cycylosporines pour administration par voie orale, de composition simple et haute biodisponibilite, et leur procede de production
US7025984B1 (en) * 2000-06-26 2006-04-11 The Procter & Gamble Company Compositions and methods for body weight management
WO2007047596A1 (fr) * 2005-10-17 2007-04-26 Hill's Pet Nutrition, Inc. Méthode de réduction de l'absorption d'aliments et de diminution de l'appétit chez les animaux

Also Published As

Publication number Publication date
ZA791056B (en) 1980-10-29
BE874628A (fr) 1979-09-05
CH636013A5 (en) 1983-05-13

Similar Documents

Publication Publication Date Title
FI65914C (fi) Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
JP4073503B2 (ja) サイクロスポリンを含有する液体製剤とその調製方法
KR100257841B1 (ko) 사이클로스포린-함유약학적조성물
KR100452003B1 (ko) 정맥내주사용라파마이신제형
RU2174405C2 (ru) Композиция циклоспорина для перорального введения (варианты) и способ достижения иммуносупрессии в организме реципиента
EP1074263B1 (fr) Compositions pharmaceutiques à base de cyclosporine comportant un acide gras hydroxyle, saturé et polyéthoxyle
EP0539319A2 (fr) Composition pharmaceutique de cyclosphorine
AU672793B2 (en) Pharmaceutical composition containing cyclosporin derivative
HU213394B (en) Process for producing pharmaceutical compositions containing cyclosporins as active components
BG60525B2 (bg) Фармацевтични състави,съдържащи циклоспорини
HU201567B (en) Process for production of intravenous medical compositions containing cyclosphorin
JPH06511263A (ja) 注射可能なレシチンのゲル
HU182920B (en) Process for preparing stable pharmaceutical compositions containing cyclosporin
AU628787B2 (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceuticals excipients
KR100294935B1 (ko) 경구용 시클로스포린 제제
KR100300251B1 (ko) 사이클로스포린함유약학적조성물
JPS631923B2 (fr)
KR100256007B1 (ko) 사이클로스포린을 함유하는 약학 조성물
KR19990047897A (ko) 사이클로스포린 함유 약학적 조성물
SA89100046B1 (ar) التركيبات الصيدلية المشتملة على السيكلوسبورينات cycclosporins

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HPC4 Succession in title of patentee

Owner name: NOVARTIS AG, CH